SILVERARC CAPITAL MANAGEMENT, LLC
CIK 1816307 · Holdings on Sep 30, 2024 · First reported Nov 14, 2024
Top ten holdings
Q3 2024- NUVL8.56%
- MRUS7.15%
- INSM5.72%
- RNA4.92%
- ERAS4.27%
- AKRO4.14%
- VCYT3.61%
- RYTM3.02%
- COGT2.97%
- ITCI2.76%
Share classes counted separately47.12%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- INSMWeight increased · +3.40 pp2.32% → 5.72%Shares +207.69K (+148.35%)
- VCYTWeight increased · +2.10 pp1.51% → 3.61%Shares +188.32K (+66.72%)
- URGNWeight decreased · -1.99 pp4.57% → 2.58%Shares -200.87K (-18.23%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 27
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NUVLNUVALENT INC-A View history and evidence | $38.00M | 8.56% | 371.44K shares | 8.72% → 8.56%-0.16 pp -94.27K (-20.24%) | Reduced | ↗▾ |
| 02 | MRUSMERUS NV View history and evidence | $31.75M | 7.15% | 635.44K shares | 9.11% → 7.15%-1.96 pp +11.81K (+1.89%) | Added | ↗▾ |
| 03 | INSMINSMED INCCOM PAR $.01 View history and evidence | $25.38M | 5.72% | 347.69K shares | 2.32% → 5.72%+3.40 pp +207.69K (+148.35%) | Added | ↗▾ |
| 04 | RNAAVIDITY BIOSCIENCES INC View history and evidence | $21.84M | 4.92% | 475.56K shares | 5.22% → 4.92%-0.30 pp -42.18K (-8.15%) | Reduced | ↗▾ |
| 05 | ERASERASCA INC View history and evidence | $18.96M | 4.27% | 6.95M shares | 4.55% → 4.27%-0.28 pp -870.44K (-11.14%) | Reduced | ↗▾ |
| 06 | AKROAKERO THERAPEUTICS INC View history and evidence | $18.36M | 4.14% | 639.84K shares | 3.62% → 4.14%+0.52 pp +14.75K (+2.36%) | Added | ↗▾ |
| 07 | VCYTVERACYTE INC View history and evidence | $16.02M | 3.61% | 470.56K shares | 1.51% → 3.61%+2.10 pp +188.32K (+66.72%) | Added | ↗▾ |
| 08 | RYTMRHYTHM PHARMACEUTICALS INC View history and evidence | $13.39M | 3.02% | 255.58K shares | 1.87% → 3.02%+1.15 pp +70.92K (+38.40%) | Added | ↗▾ |
| 09 | COGTCOGENT BIOSCIENCES INC View history and evidence | $13.19M | 2.97% | 1.22M shares | 2.51% → 2.97%+0.46 pp +15.15K (+1.26%) | Added | ↗▾ |
| 10 | ITCIINTRA-CELLULAR THERAPIES INC View history and evidence | $12.23M | 2.76% | 167.11K shares | 3.25% → 2.76%-0.49 pp -25.23K (-13.12%) | Reduced | ↗▾ |
Options overlay 3
$1.54M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
CCCCC4 THERAPEUTICS INCCALL View history and evidence | Call | 150.00K | $855.00K | +150.00K | ▾ |
CRBPCORBUS PHARMACEUTICALS HOLDICALL View history and evidence | Call | 17.80K | $367.21K | +17.80K | ▾ |
59045L106MERSANA THERAPEUTICS INCCALL View history and evidence | Call | 168.30K | $318.09K | +168.30K | ▾ |
3 / 3 options · preview only
Exited positions 15
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| INSM INSMED INC | Call | -250,000 | -$16.75M | SEC filing ↗ | SEC filing ↗ |
| MORF MORPHIC HOLDING INC | Non-derivative | -486,306 | -$16.57M | SEC filing ↗ | SEC filing ↗ |
| CRBP CORBUS PHARMACEUTICALS HOLDI | Non-derivative | -172,492 | -$7.81M | SEC filing ↗ | SEC filing ↗ |
3 / 15 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1816307 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2024-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 445291323
}Research all 71 reported holdings.
This page includes 30 of 71 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 71 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1816307","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1816307","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.